JP5558458B2 - 普通感冒の治療用の医薬の製造における物質の使用 - Google Patents

普通感冒の治療用の医薬の製造における物質の使用 Download PDF

Info

Publication number
JP5558458B2
JP5558458B2 JP2011500740A JP2011500740A JP5558458B2 JP 5558458 B2 JP5558458 B2 JP 5558458B2 JP 2011500740 A JP2011500740 A JP 2011500740A JP 2011500740 A JP2011500740 A JP 2011500740A JP 5558458 B2 JP5558458 B2 JP 5558458B2
Authority
JP
Japan
Prior art keywords
hydrogen peroxide
oxidase
glucose oxidase
glucose
common cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011500740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011515391A5 (enExample
JP2011515391A (ja
Inventor
クリステル・タノ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanomed AB
Original Assignee
Tanomed AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanomed AB filed Critical Tanomed AB
Publication of JP2011515391A publication Critical patent/JP2011515391A/ja
Publication of JP2011515391A5 publication Critical patent/JP2011515391A5/ja
Application granted granted Critical
Publication of JP5558458B2 publication Critical patent/JP5558458B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011500740A 2008-03-20 2009-03-20 普通感冒の治療用の医薬の製造における物質の使用 Expired - Fee Related JP5558458B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0800658 2008-03-20
SE0800658-7 2008-03-20
PCT/SE2009/050291 WO2009116944A1 (en) 2008-03-20 2009-03-20 Use of a substance for manufacturing of a medicament for treatment of common cold

Publications (3)

Publication Number Publication Date
JP2011515391A JP2011515391A (ja) 2011-05-19
JP2011515391A5 JP2011515391A5 (enExample) 2012-04-05
JP5558458B2 true JP5558458B2 (ja) 2014-07-23

Family

ID=41091160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011500740A Expired - Fee Related JP5558458B2 (ja) 2008-03-20 2009-03-20 普通感冒の治療用の医薬の製造における物質の使用

Country Status (8)

Country Link
US (1) US8895282B2 (enExample)
EP (1) EP2276505B1 (enExample)
JP (1) JP5558458B2 (enExample)
CN (1) CN101977625A (enExample)
DK (1) DK2276505T3 (enExample)
ES (1) ES2436037T3 (enExample)
PL (1) PL2276505T3 (enExample)
WO (1) WO2009116944A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
US10213491B2 (en) * 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
US20180280483A1 (en) * 2015-08-21 2018-10-04 Morinaga Milk Industry Co., Ltd. Agent for protecting upper respiratory tract and food or drink composition for protecting upper respiratory tract
CA3038590A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN112105378B (zh) 2018-01-03 2025-03-11 宾夕法尼亚州研究基金会 作为新生儿抗惊厥药的葡萄糖氧化酶组合物
CN112351766A (zh) 2018-06-25 2021-02-09 璀昂芬制药公司 使用含锌的组合物抑制微生物感染的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1992014484A1 (en) 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
GB2285218A (en) * 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
GB9406075D0 (en) 1994-03-26 1994-05-18 Boots Co Plc Method of killing microorganisms
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1999002148A1 (en) * 1997-07-11 1999-01-21 The Johns Hopkins University School Of Medicine Nitric oxide inhibits rhinovirus infection
DE29723959U1 (de) 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
AU7584500A (en) 1999-09-17 2001-04-17 Smithkline Beecham Corporation Use of csaids in rhinovirus infection
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US6214339B1 (en) 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
AR030753A1 (es) 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
SE0200876L (sv) 2002-03-22 2003-09-23 Krister Tano Nässpray mot öroninflammationer
CN1408358A (zh) * 2002-09-20 2003-04-09 高艺歌 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
WO2005113026A2 (en) 2004-04-22 2005-12-01 Medical Discoveries, Inc. Method of treating respiratory disorders and airway inflammation
US20070026085A1 (en) 2005-07-26 2007-02-01 Global Life Technologies Corp. Antimicrobial and antiviral composition
BRPI0617481A2 (pt) 2005-10-21 2011-07-26 Danisco composiÇço que compreende um sistema enzimÁtico acoplado

Also Published As

Publication number Publication date
EP2276505B1 (en) 2013-09-18
JP2011515391A (ja) 2011-05-19
DK2276505T3 (da) 2013-11-25
EP2276505A1 (en) 2011-01-26
US8895282B2 (en) 2014-11-25
EP2276505A4 (en) 2011-06-22
CN101977625A (zh) 2011-02-16
PL2276505T3 (pl) 2014-01-31
ES2436037T3 (es) 2013-12-26
US20110044966A1 (en) 2011-02-24
WO2009116944A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
JP5558458B2 (ja) 普通感冒の治療用の医薬の製造における物質の使用
AU2019202045B2 (en) Treatment of Microbial Infections
AU2007329708B2 (en) Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
WO2001019385A9 (en) The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
CN107847527A (zh) 微生物感染的预防和治疗
US20110135621A1 (en) Inhibiting bacterial infection and biofilm formation
JP2014028821A (ja) 気道中の生物膜を溶解するための加水分解酵素および酸化酵素の使用
CN105263489B (zh) 抗微生物组合物及其制造方法
CN111991414B (zh) 一种β-壳糖胺在制备预防和治疗新冠肺炎病毒感染的药物中的用途
US20230233488A1 (en) Novel use of a modulator of glucosylceramide degradation for viral infections
WO2007106675A2 (en) Composition and method of retarding viral activity and reducing viral replication
WO2022161381A1 (zh) 血管内皮抑制素在治疗和预防冠状病毒相关疾病中的应用
WO2022162254A1 (es) Composición para su uso en forma de gotas nasales y nebulizadores como antiviral
EP3015110A1 (en) Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
HK1225961B (zh) 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131112

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140513

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140604

R150 Certificate of patent or registration of utility model

Ref document number: 5558458

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees